ASTS Stock Sinks 14% After BlueBird 7 Satellite Orbital Failure

AST SpaceMobile (ASTS) stock dropped roughly 14% on Monday, April 20, after the company confirmed its BlueBird 7 satellite was placed into a lower-than-planned orbit during the New Glenn 3 mission, making normal operations impossible. The satellite will be de-orbited, though the company expects the loss to be covered under insurance. Management attempted to reassure investors by reiterating its target of 45 satellites in orbit by year-end, but the market reaction was swift and severe.

Key Drivers of the ASTS Stock Move

The BlueBird 7 loss compounds an already challenging stretch for ASTS. The Amazon-Globalstar deal announced mid-April sparked initial concern about competitive dynamics in the direct-to-device market, and the stock had already been pulling back before this failure. While insurance coverage limits the immediate financial hit, satellite deployment timelines now face tighter scrutiny. The core risk is not any single satellite loss but the cumulative pressure on an ambitious build-out schedule in a sector where launch capacity is increasingly bottlenecked.

ASTS Smart Money Activity

The most notable insider activity comes from Hiroshi Mikitani, a 10%+ owner, who sold approximately $270.9M worth of ASTS shares across two transactions on April 14 and 15, disposing of 3.04 million shares combined. This is a large, concentrated sale from a major holder, executed just days before the BlueBird 7 failure became public knowledge. On the institutional side, no congressional trades were recorded for ASTS in 2026. Earlier in March, CEO Abel Avellan and other executives received stock awards, which are routine compensation actions.

ASTS Unusual Options

Options flow on April 20, the day of the crash, was notably mixed but leaned bullish in aggregate, suggesting dip-buyers stepped in aggressively. Large bullish sweeps dominated earlier in the session on near-term calls such as the Apr 24 $80 call ($275K premium), May 15 $75 calls (multiple sweeps totaling over $364K combined), and longer-dated Jan 2028 $80 calls ($280K+). Bearish flow also appeared, including a Jan 2027 $90 put block worth $959K and a Jan 15 2027 $150 put trade at $162.7K. Today (April 21), a large bullish sweep on the Jan 2028 $100 call ($247K) and a notable $322.5K trade on Sep 2026 $55 puts (tagged bullish at bid) reflect continued two-sided conviction. The size and frequency of long-dated call activity suggests a subset of traders is using the dip to build longer-term exposure.

ASTS Analyst Focus

• Downgrades: ScotiaBank downgraded to sell with a $45.60 price target (January 7). B. Riley downgraded to hold in January (target raised to $105 at the time).
• Confirms/Maintains: Barclays maintains underweight with a $65 target (April 9). UBS confirmed hold with target raised from $43 to $85 (March 4). B. Riley reconfirmed hold, lowering target back to $95 (February 13).
• Median price target (from available data): Approximately $85, with the range spanning $45.60 (ScotiaBank bear case) to $105 (B. Riley high). Notably, no analyst in this data set carries an active buy rating, which is a meaningful signal given the current stock price near $82.

ASTS Seasonality

Based on data since January 2020 (approximately 6-7 samples per month), April is historically the weakest month of the year for ASTS, with an average return of -9.6% and only 43% of Aprils finishing positive. That tracks with the current move. September (-10.8% average, 33% positive) is the only month with comparable weakness. On the positive side, May (+44.8% average, 50% positive) and June (+31.1%, 67% positive) are historically the two strongest months of the year, suggesting a potential seasonal recovery window may be approaching. Note: sample sizes are small (6-7 years), so these figures carry meaningful statistical uncertainty.

ASTS Relative Performance

ASTS has seen a sharp deterioration in sector-relative performance throughout 2026. At the start of the year, it ranked at the 98th to 99th percentile versus same-sector peers on a trailing 1-year basis. By late March, that had already slipped into the mid-90s as the Amazon-Globalstar competitive threat emerged. The BlueBird 7 failure on April 20 knocked the reading down to 86.1, the lowest reading in this year-to-date data set. The stock is still outperforming most of its sector on a trailing 1-year basis, but the trend is clearly deteriorating and accelerating to the downside.